Tag: biosimilar coding
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
How to Choose the Right Generic Medication When Multiple Options Are Available
Dec, 3 2025
How to Store Controlled Substances to Prevent Diversion: A Practical Guide for Healthcare Facilities
Nov, 16 2025
Smart Prescription Savings: Fintech Solutions vs Coupon Apps
Aug, 9 2025
The Importance of Regular Hearing Tests for Early Detection of Hearing Difficulty
Sep, 4 2023
Workplace Accommodations for Medication Side Effects: What You Need to Know
Dec, 2 2025